Articles

Towards an FDA-cleared Basophil Activation Test
Posted on: 19-Nov-2024
Food allergy is a global health problem affecting up to 10% of the world population. Accurate diagnosis of food allergies, however, is still a major challenge in medical offices and for patients seeking alternative avenues of diagnosis. A flawless test to confirm or rule out a food allergy does not exist.
Read more
GSK to cap out-of-pocket inhaler costs in US
Posted on: 07-Apr-2024
March 20 (Reuters) - British pharmaceutical giant GSK (GSK.L), opens new tab said on Wednesday it would cap out-of-pocket costs for all its inhaled asthma and chronic lung disease medicines at $35 per month for eligible patients in the United States, following similar moves by two of its rivals.
Read more
Takeda's treatment becomes first oral therapy for esophageal condition in US
Posted on: 05-Mar-2024
Feb 12 (Reuters) - Takeda Pharmaceutical's (4502.T) therapy for an allergic inflammation of the esophagus has received approval from the U.S. FDA, the Japanese drugmaker said on Monday, capping a years-long regulatory process.
Read more
Extensively Drug-Resistant Pseudomonas aeruginosa Outbreak associated with Artificial Tears
Posted on: 12-Feb-2024
Carbapenemase-producing, carbapenem-resistant Pseudomonas aeruginosa (CP-CRPA) are extensively drug resistant bacteria. We investigated the source of a multistate CP-CRPA outbreak.
Read more
Health Headlines: New hope for children with peanut allergies
Posted on: 05-Sep-2023
ATLANTA, Ga. (Ivanhoe Newswire) – More than five and a half million kids have a food allergy, that’s about one in 13 kids, or one or two kids in every single classroom. Even though more than 170 foods have been reported to cause allergies, eggs, milk, and peanuts are the most common. Recently, the FDA approved an oral treatment for older children with peanut allergies, but there was no treatment for children under the age of four, until now.
Read more